of U.S. government funding for one or more of the Company's development programs, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, technology transfer, and/or process...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to PharmAthene Completes Closing Arguments And Provides Update On Litigation With SIGA Technologies
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account